Pay in 4 interest-free payments of $6.22 Learn more
Ships within 48 hours · Estimated delivery Sep 26 - Oct 1
The reactive thiol of roGFP2 attacks this disulfide and glutathione is transferred to roGFP2 by a disulfide exchange reaction
Pharmacokinetics in patients with impaired hepatic function study design, data analysis and impact on dosing and labeling
After years of work, the FDA approved this type of drug for diabetes
Interestingly, a recent study reported a greater exposure to crizotinib and its active metabolite PF-06260182 in subjects with severe renal impairment (creatinine clearance 25%) were increased AST/ALT, lymphopenia, increased ALP, hypocalcemia, neutropenia, thrombocytopenia, hypophosphatemia, and hyperbilirubinemia
US$ 28.77
US$ 24.76
US$ 28.46
US$ 26.61
US$ 28.86
US$ 22.74
US$ 21.71
US$ 24.64
